With the ongoing dramatic growth of radiopharmaceutical therapy, research and development
in internal radiation dosimetry continue to advance both at academic medical centers and …

Commercial reentrant ionization chambers (‘dose calibrators’) have become the de facto
standard instrument for making radioactivity measurements in the radiopharmaceutical industry…

… Author links open overlay panel Brian E. Zimmerman 1 , Darko Grošev 2 , Irène Buvat 3 ,
Marco A. Coca Pérez 4 , Eric C. Frey 5 , Alan Green 6 , Anchali Krisanachinda 7 , Michael …

We have developed a methodology for calibrating 68 Ge radioactivity content in a
commercially available calibration source for activity calibrators in a way that is traceable to the …

A method for preparation of Pb-212 and Pb-203 labeled chelator-modified peptide-based
radiopharmaceuticals for cancer imaging and radionuclide therapy has been developed and …

Receptor-targeted image-guided Radionuclide Therapy (TRT) is increasingly recognized as
a promising approach to cancer treatment. In particular, the potential for clinical translation …

A description of the triple-to-double coincidence ratio (TDCR) spectrometer recently
constructed at NIST and results of tests to assess its operating characteristics are presented. …

Accurate, reproducible measurement of radioactivity in nuclear medicine applications is vital
to ensure the safety and effectiveness of disease diagnosis and treatment using unsealed …

Radiopharmaceutical therapy (RPT) continues to demonstrate tremendous potential in
improving the therapeutic gains in radiation therapy by specifically delivering radiation to tumors …

A solution containing 68 Ge in equilibrium with its daughter, 68 Ga, has been standardized
for the first time at the National Institute of Standards and Technology (NIST) using 3 liquid …